Education Library

This case study describes how escalation of support to Impella 5.5 with SmartAssist enabled heart recovery in a 33-year-old woman with postpartum myocarditis.
 

Amir Kaki, MD, describes best practices and practical considerations for optimizing care of patients with AMI cardiogenic shock prior to leaving the cath lab.

Bobby Yeh, MD, discusses how real-world evidence factors into treatment decisions made every day in clinical practice.

Arman Kilic, MD, discusses his experiences with collaboration between interventional cardiology and cardiac surgery, particularly regarding Impella 5.5® with SmartAssist® and ECpella™.

Navin Kapur, MD, discusses the latest science underlying reperfusion and unloading and how it led to the STEMI-DTU pilot and pivotal trials.

Kate Kearney, MD, discusses studies and strategies for revascularization in heart failure with reduced ejection fraction.

Adam DeVore, MD, reviews data on evaluating patients with heart failure for CAD and discusses opportunities to improve assessment rates for CAD in these patients.

Gregg Stone, MD, presents the newly underway PROTECT IV randomized controlled transcatheter heart failure therapy trial at THT 2022.

This patient case study illustrates how unloading with Impella 5.5® with SmartAssist® enabled coronary reperfusion and complete revascularization.

Mario Iannaccone, MD, discusses his meta-analysis data supporting pre-PCI placement of Impella® for AMI cardiogenic shock.

A bicarbonate-based purge solution for Impella® may be a viable alternative to heparin-based purge solution in patients who are heparin-intolerant and when heparin is contraindicated.

A Heart Team approach and hemodynamic assessment led to timely and effective use of Impella 5.5 with SmartAssist for this patient with PCCS.

Claudius Mahr, DO, discusses outcome differences between patients with acute de novo cardiogenic shock and patients with chronic heart failure deteriorating to shock.

Zubair Shah, MD, explains how his research revealed improved outcomes in patients with cardiogenic shock receiving right heart catheterization.

Federico Pappalardo, MD, describes the role of IABP in the treatment of acute-on-chronic heart failure complicated by cardiogenic shock.